Designing better antibody drugs with artificial intelligence Research ETH Zurich Machine learning methods help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body. Previous 19 20 21 22 23 24 25 26 Page 26 of 26
